Legal & General Group’s CalciMedica CALC Stock Holding History

Legal & General Group’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-49	Closed	-$4K	–	3507
2021 Q1	$4K	Hold	49	–	–	﹤0.01%	3497
2020 Q4	$20K	Buy	+49	New	+$14.5K	﹤0.01%	3083

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

Legal & General Group's CALC Position: Q2 2021 in Review

Legal & General Group sold out of CalciMedica (CALC) in Q2 2021, closing a stake of 49 shares — an estimated $4K sold.

Legal & General Group first reported a position in CALC in Q4 2020 and held it in 2 quarters. The position peaked at $20K in Q4 2020. 41 funds tracked by Wall St. Rank hold CALC as of Q2 2021.

Legal & General Group reported no remaining CalciMedica position as of Q2 2021 after selling out during the quarter.
Legal & General Group sold 49 CalciMedica shares in Q2 2021, an estimated $4K.
Legal & General Group first reported a position in CalciMedica in Q4 2020 and held it in 2 quarters.
Legal & General Group's CalciMedica position peaked at $20K in Q4 2020.
41 funds tracked by Wall St. Rank held CalciMedica as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.